143 related articles for article (PubMed ID: 28152272)
1. Radiolabeling, quality control, and biological characterization of
Akbar MU; Bokhari TH; Khalid M; Ahmad MR; Roohi S; Hina S; Mehmood S; Sohaib M; Jabbar T
Chem Biol Drug Des; 2017 Sep; 90(3):425-431. PubMed ID: 28152272
[TBL] [Abstract][Full Text] [Related]
2. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
[TBL] [Abstract][Full Text] [Related]
3. Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2012 Aug; 39(6):763-9. PubMed ID: 22459337
[TBL] [Abstract][Full Text] [Related]
4. Radiosynthesis, radiochemical, and biological characterization of
Akbar MU; Bokhari TH; Ahmad MR; Zia KM; Roohi S; Ayub N; Sohaib M
J Cell Biochem; 2019 Sep; 120(9):14510-14517. PubMed ID: 30994957
[TBL] [Abstract][Full Text] [Related]
5. (177) Lu-5-Fluorouracil a potential theranostic radiopharmaceutical: radiosynthesis, quality control, biodistribution, and scintigraphy.
Rasheed R; Tariq S; Naqvi SA; Gillani SJ; Rizvi FA; Sajid M; Rasheed S
J Labelled Comp Radiopharm; 2016 Aug; 59(10):398-403. PubMed ID: 27444959
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.
Koumarianou E; Mikołajczak R; Pawlak D; Zikos X; Bouziotis P; Garnuszek P; Karczmarczyk U; Maurin M; Archimandritis SC
Nucl Med Biol; 2009 Aug; 36(6):591-603. PubMed ID: 19647165
[TBL] [Abstract][Full Text] [Related]
7. Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer.
Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
Nucl Med Biol; 2008 Jul; 35(5):589-97. PubMed ID: 18589303
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeling, quality control, biodistribution, and imaging studies of
Xu Q; Zhang S; Zhao Y; Feng Y; Liu L; Cai L; Zhang W; Huang Z; Wei H; Zhuo L; Chen Y
J Labelled Comp Radiopharm; 2019 Jan; 62(1):43-51. PubMed ID: 30426535
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
Giblin MF; Sieckman GL; Shelton TD; Hoffman TJ; Forte LR; Volkert WA
Nucl Med Biol; 2006 May; 33(4):481-8. PubMed ID: 16720239
[TBL] [Abstract][Full Text] [Related]
10. Preparation, optimization and pharmacological evaluation of
Akbar MU
Mol Biol Rep; 2018 Dec; 45(6):2717-2723. PubMed ID: 30328001
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m radiolabeling and biological study of epirubicin for in vivo imaging of multi-drug-resistant Staphylococcus aureus infections via single photon emission computed tomography.
Khan NUH; Naqvi SAR; Roohi S; Sherazi TA; Khan ZA; Zahoor AF
Chem Biol Drug Des; 2019 Feb; 93(2):154-162. PubMed ID: 30216686
[TBL] [Abstract][Full Text] [Related]
12. Production, quality control, and determination of human absorbed dose of no carrier added
Salek N; Mehrabi M; Shirvani Arani S; Bahrami Samani A; Erfani M; Vosoghi S; Ghannadi Maragheh M; Shamsaei M
J Labelled Comp Radiopharm; 2017 Jan; 60(1):20-29. PubMed ID: 27862203
[TBL] [Abstract][Full Text] [Related]
13. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
[TBL] [Abstract][Full Text] [Related]
14. (99m)Tc-daunorubicin a potential brain imaging and theranostic agent: synthesis, quality control, characterization, biodistribution and scintigraphy.
Faheem AR; Bokhari TH; Roohi S; Mushtaq A; Sohaib M
Nucl Med Biol; 2013 Jan; 40(1):148-52. PubMed ID: 23146307
[TBL] [Abstract][Full Text] [Related]
15. Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
Chakraborty S; Sarma HD; Vimalnath KV; Pillai MR
Nucl Med Biol; 2013 Oct; 40(7):946-54. PubMed ID: 23850487
[TBL] [Abstract][Full Text] [Related]
16. Preparation of clinical-scale
Guleria M; Das T; Kumar C; Amirdhanayagam J; Sarma HD; Banerjee S
J Labelled Comp Radiopharm; 2017 May; 60(5):234-241. PubMed ID: 28181275
[TBL] [Abstract][Full Text] [Related]
17. Pyridine-containing octadentate ligand NE3TA-PY for formation of neutral complex with
Chong HS; Chen Y; Kang CS; Sin I; Zhang S; Wang H
J Inorg Biochem; 2021 Aug; 221():111436. PubMed ID: 33971521
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Radiolabeling, and Characterization of Plasma Protein-Binding Ligands: Potential Tools for Modulation of the Pharmacokinetic Properties of (Radio)Pharmaceuticals.
Müller C; Farkas R; Borgna F; Schmid RM; Benešová M; Schibli R
Bioconjug Chem; 2017 Sep; 28(9):2372-2383. PubMed ID: 28898054
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, quality control, and bio-evaluation of
Bokhari TH; Roohi S; Hina S; Akbar MU; Sohaib M; Iqbal M
Chem Biol Drug Des; 2018 Feb; 91(2):456-462. PubMed ID: 28886237
[TBL] [Abstract][Full Text] [Related]
20. Development of a new bombesin analog radiolabeled with lutetium-177: in vivo evaluation of the biological properties in Balb-C mice.
Pujatti PB; Santos JS; Massicano AV; Mengatti J; De Araújo EB
Cell Mol Biol (Noisy-le-grand); 2010 May; 56(2):18-24. PubMed ID: 20525454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]